Delivery Order SPE2DB22D1017-SPE2DB25FYSKS
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 36mg, with a ceiling value of $1,849.39. This firm fixed-price, non-set-aside contract was awarded on June 6, 2025, with an ultimate completion date of June 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order serves as a child contract under the company's existing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,948.54 on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $15,296.82 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This award represents a child contract under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 54 mg tablets (100-count units) valued at $1,199.34, with a firm fixed price arrangement. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,139.22 to AmerisourceBergen Drug Corp for 27mg Concerta ER tablets on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with the Defense Logistics Agency. The pharmaceutical products will be delivered to the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $9,033.73. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) under a firm fixed-price contract valued at $3,260.42, with an ultimate completion date of September 26, 2025. This non-set-aside competitive award was issued on September 25, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $57,644.29 for Concerta ER Tablets 27mg under a Defense Logistics Agency (DLA) Medical Supply Chain contract. This competitively awarded, firm fixed-price delivery order was executed on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract carries no set-aside designation and represents a child award under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used in the treatment of attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $33,063.14, represents a non-set-aside competitive award and is scheduled for ultimate completion by August 8, 2025. The contract will be performed at...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSKSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count) with a contract value of $6,339.04. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement is well-established, with an extensive portfolio of delivery orders covering brand-name and generic medications across multiple therapeutic domains. The DLA Troop Support Medical contract enables the company to supply pharmaceutical products, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This particular delivery order for Concerta ER, a controlled-release methylphenidate medication commonly used for attention deficit hyperactivity disorder treatment, reflects the company's ongoing capability to fulfill specialized pharmaceutical supply requirements for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 9/29/25 |